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Enterovirus 71 (EV71) is amajor causative agent of hand, foot, andmouth disease (HFMD) in children.The role of T follicular helper
(TFH) cells in EV71-infected children remains unclear in regulating humoral immunity.The frequency of circulating ICOShigh/PD-
1highCXCR5+CD4+ TFH cells in the children with mild and severe EV71 infection and healthy controls (HC) was detected by flow
cytometry, respectively. IL-21 and IL-6mRNA expression and their serum levels, Bcl-6 mRNA expression, and specific neutralizing
antibodies against EV71 (NAb-EV71) were measured. In the acute stage of patients with EV71 infection, increased frequencies
of circulating TFH cells with ICOShigh and PD-1high expression in the mild and severe patients were observed, and the positive
correlations among the frequencies of circulating TFH cells and the serum levels of IL-21, IL-6, and NAb-EV71 titres were detected,
respectively. Moreover, the expressions of IL-6 and IL-21 mRNA in PBMCs from patients were also significantly higher than those
of HC. However, further analysis did not reveal any significant differences between mild and severe patients. These data indicate a
role of TFH cells and associated cytokines in modulating the humoral response during the pathogenesis of EV71 infection.
1. Introduction
Enterovirus 71 (EV71) is a positive-stranded RNA genome
and belongs to a member of the species A, Enterovirus genus,
Picornaviridae family [1]. EV71 is one of the major causative
agents of hand, foot, and mouth disease (HFMD) in young
children, which has caused a series of outbreaks of HFMD
throughout the world, with particular prevalence in Asian-
Pacific region [2–6]. Most HFMD cases are mild, and self-
limited disease is caused mainly by EV71 and Coxsackievirus
A16 (CA16), but HFMD cases caused by EV71 have resulted
in severe neurological complications, pulmonary edema, and
fetal death; EV71 has become a serious public health concern
[5–8]. Currently, there is no safe and effective vaccine avail-
able for prevention and control of this disease. There is also
no approved antiviral drug for treatment of EV71 infection.
Recent studies suggest that neutralizing antibodies (NAb)
against EV71 (NAb-EV71) are crucial for the protection from
EV71 infection in animals and young children [4–6].
In an adaptive immune response, Th1 and Th2 subsets
of CD4+ helper T cells are considered to play a pivotal role
in helping B cells to class-switch Ig isotypes via secreting
special cytokines, such as IFN-𝛾 and IL-4 and Th1 and
Th2 cytokines, respectively [9]. Recently, T follicular helper
(TFH) cells have been clearly described as a specialized
subset of CD4+ T cells, which distinguish from Th1, Th2,
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Th17, and Treg and localize to B cell follicles of germinal
center (GC), where they can regulate the humoral immune
responses [10–14]. Typical features of TFH cells are the
expression of chemokine (C-X-Cmotif) receptor 5 (CXCR5),
inducible costimulator (ICOS), programmed death-1 (PD-1),
interleukin- (IL-) 21, and B-cell lymphoma 6 (BCL-6) [14–16].
Additionally, TFH cells also express other surface molecules
including CD40 ligand (CD40L), OX40, IL-21 receptor (IL-
21R), and IL-6 receptor (IL-6R) [14]. TFH cells can migrate
to C-X-C motif chemokine 13 (CXCL13) expressed on B
cells through CXCR5, which is carried out in GC, where
TFH cells and relative cytokines regulate the development
of B-cells responses as well as Ig isotype switching and the
production of optimal antibodies [17–20]. Studies indicated
that ICOS and PD-1 of the CD28 family members are closely
correlated with the functions of TFH cells; some cytokines
such as IL-6, IL-12, IL-21, and IL-23 can induce IL-21 secretion
in human na¨ıve CD4+ T cells, but only IL-12 induces the
sustained expression of CXCR5 and ICOS on these activated
na¨ıve CD4+ T cells, which promotes TFH cell development
by upregulation of BCL-6 expression [20–25]. Bcl-6 is an
essential transcriptional factor that directly affects TFH cells
differentiation and represses transcriptional regulators of
other Th cells [17].
Recent studies have shown that circulating TFH cells
were dysregulated in patients with lymphoma, autoimmune
diseases, and several infectious diseases [25–30]. Increasing
evidence indicates that Th1, Th2, Th17, and Treg subsets
and B cells are critically involved in the pathogenesis of
EV71 infection [31–35]. However, the role of circulating TFH
cells is not yet characterized in regulating humoral immune
response in EV71-infected children. In this study, we reported
that the frequency of circulating TFH cells and levels of NAb-
EV71, IL-21, and IL-6 mRNA expression were significantly
increased in patients at the acute stage of EV71 infection,
compared to HC. Additionally, the frequency of circulating
CXCR5+CD4+ TFH cells with ICOShigh and PD-1high was
positively correlatedwith levels of IL-21, IL-6, andNAb-EV71.
These data indicated that the TFH cell might play a crucial
role in the pathogenesis of HFMD at acute stage of EV71
infection.
2. Materials and Methods
2.1. Patients. A total of 60 children below ten years with
EV71 infections acquired during outbreaks betweenApril and
September 2013 in the First Affiliated Hospital of College
of Medicine, Zhejiang University. The diagnoses were estab-
lished depending on clinical features and laboratory criteria.
EV71-infected HFMD was defined by EV71-positive throat
swabs, stools, rectal swabs, vesicular swabs, or cerebrospinal
fluid (CSF) samples which were detected using specific EV71
primers and probe from the enterovirus 71 nucleic acid
detection kit (Da An Gene Co., Ltd., Guangzhou, China).
Mild case was characterized by typical manifestations with or
without fever, which usually recovered spontaneously within
one week; severe case was defined as a febrile exanthematous
disease with neurological signs of encephalitis, meningi-
tis, and/or cardiopulmonary complications, as previously
described [3]. Clinical samples and data were collected from
the EV71-infected HFMD children who had not been treated
at the time the samples were collected in the first diagnose
in the hospital, and children with bacterial infections were
excluded.
43 healthy children with age and gender matched were
included in this study as controls from health checks requir-
ing blood puncture on parents’ request or physicians’ advice
to test for HBV infection status, liver function, and blood
routine examination at our hospital. According to the Dec-
laration of Helsinki (1964), informed consents were obtained
from the parents or guardians of the children, and themedical
ethical committee of our hospital approved this study. Main
clinical data of these children are shown in Table 1.
2.2. Cell Isolation. Peripheral blood samples were obtained
from the healthy children and the patients in the acute stage
of EV71 infection, and peripheral blood mononuclear cells
(PBMCs) were isolated by density-gradient centrifugation
using Ficoll-Hypaque solution.
2.3. Flow Cytometric Analysis. Human PBMCs were washed
and stained with PerCP/cy5.5-anti-CXCR5 and APC-anti-
CD4, PE-anti-CD278 (ICOS), and FITC-anti-CD279 (PD-
1) (Biolegend, San Diego, CA, USA). Isotype-matched Ab
controls were used in all procedures. All the staining was per-
formed according to manufacturer’s protocol. The frequency
of circulating TFH cells was determined by a FACSCalibur
flow cytometry (Beckton Dickinson, BD Bioscience, USA)
and FlowJo software version 7.6.5 (TreeStar, San Carlos, CA).
2.4. RNA Isolation and Real-Time PCR. For detection of
IL-6, IL-21, and BCL-6 mRNA expression, total RNA from
PBMCs was extracted with Trizol (Invitrogen, USA). cDNA
was synthesized by reverse transcription reagent kits (Takara,
Dalian, China) according to the manufacturer’s instruction.
Real-time PCR was performed in triplicate using Takara
SYBR super mix (Takara, Dalian, China) by ABI 7500
analysis system (Applied Biosystems, CA, USA). Amplified
conditions were as follows: 5min at 95∘C for denaturation,
then 40 cycles of 95∘C for 10 sec and 60∘C for 40 sec, and
collecting for fluorescence at 60∘C. Primer sequences were
as follows: IL-6 sense: 5󸀠-GGCCTTCCCTACTTCACAAG-
3󸀠, antisense: 5󸀠-ATTTCCACGATTTCCCAGAG-3󸀠; IL-
21 sense: 5󸀠-AGATCCAGTCCTGGCAACATG-3󸀠, antisense:
5󸀠-GGCAGAAATTCAGGGACCAAG-3󸀠; and BCL-6 sense:
5󸀠-TTGTGAGCCGTGAGCAGTTT-3󸀠, antisense: 5󸀠-TGT-
CTTGGGGCATCAGCAT-3󸀠. Each gene was normalized
using 𝛽-actin gene with the following primers: sense, 5󸀠-
TGGAATCCTGTGGCATCCATGAAAC-3󸀠; antisense, 5󸀠-
TAAAACGCAGCTCAGTAACAGTCCG-3󸀠. Data were ana-
lyzed by ABI 7500 Software (Applied Biosystems, CA, USA).
2.5. Enzyme-Linked Immunosorbent Assay (ELISA). Serum
samples were stored at −80∘C. The levels of the sera IL-6
and IL-21 in individual children and healthy controls were
measured by enzyme-linked immunosorbent assay (ELISA)
Journal of Immunology Research 3
Table 1: Clinical characteristics of 60 recruited children with HFMD caused by EV71 infection.
Group Number M/F Age (Months) WBC (×109) CRP (mg/L)
Mild 29 16/13 46.41 ± 18.01 7.90 ± 1.84 6.95 ± 4.80
Severe 31 20/11 26.19 ± 12.98 13.11 ± 4.16 19.39 ± 11.91
HC 43 23/20 37.44 ± 11.14 6.34 ± 1.11 0.31 ± 0.10
Note: data correspond to the arithmetic mean ± SD. M/F: male/female; WBC: white blood cell; CRP: C-reactive protein; HC: healthy controls.
60 Laboratory-confirmed HFMD children with EV71 infection were recruited and classified into two groups according to the clinical severity of disease and
degrees of neurological damage.
using LEGEND MAX Human IL-6 ELISA Kit with Pre-
coated Plates and LEGEND MAX Human IL-21 ELISA Kit
with Pre-coated PlatesELISA kits (Biolegend, San Diego,
CA, USA) according to the manufacturer’s instructions. All
samples were run in triplicate.
2.6. Neutralizing Antibody (NAb) against EV71 Assay
(NAb-EV71). Neutralizing antibodies (NAb) against EV71
(Zhejiang/DTID/ZJU-74) in sera was detected by a micro-
neutralization test in 96-well plates, as described previously
[3]. Briefly, the sera inactivated at 56∘C for 30 minutes were
serially diluted from 1 : 8 to 1 : 1,024 in DMEM containing
2% fetal bovine serum. Serum dilution (25𝜇L) and 25 𝜇L
viral cultures with 100 fifty percent tissue culture infective
dose (TCID
50
) were mixed and incubated at 37∘C for 2
hours. The serum-virus mixtures were then added into
100 𝜇L of human rhabdomyosarcoma (RD) cell suspension
(2 × 105 cells/mL), incubated at 37∘C for 3 days in 5% CO
2
,
and monitored for characteristic cytopathic effect (CPE).
The neutralizing titer was defined as the reciprocal of the
dilution of the serum that neutralized ≥50% of the infected
cells. If the serum neutralization titer was ≥1 : 8, the specific
neutralizing antibody (NAb) against EV71 was considered
to be positive. An antibody-negative serum and uninfected
cells were defined as controls.
2.7. Statistical Analysis. One-way ANOVA analysis was per-
formed to confirm whether there was an overall statistically
significant change among the groups. Student’s 𝑡-test was per-
formed as appropriate. Correlations between variables were
determined using Spearman’s correlation coefficient. Data
were analyzed using GraphPad Prism 5 software (GraphPad
Software, Inc., San Diego, CA).
3. Results
3.1. Increased Frequency of Circulating CXCR5+CD4+ TFH
Cells in Children with EV71 Infection. To identify the viral eti-
ology of HFMD from each child in our recruited population,
60 children with EV71-mediated HFMD were identified by
one-step real-time RT-PCR assay for at least one of clinical
samples from throat swabs, stools, rectal swabs, vesicular
swabs, or CSF. 31 cases were considered to be severe HFMD
with CNS involvement, and 29 cases were mild according to
clinical symptoms (Table 1). We found that severe patients
occurred below 3 years; the number of peripheral bloodWBC
and the concentration of CRP were notably different among
the severe, mild, and HC groups.
To explore the potential role of circulating TFH cells in
EV71-mediated HFMD children, the frequency of circulating
CXCR5+CD4+ TFH cells and the percentages of ICOShigh or
PD-1highCXCR5+CD4+ TFH cells were analyzed using flow
cytometry (Figures 1(a)–1(c)). The frequencies of circulating
CXCR5+CD4+ TFH cells in CD4+ T cells in bothmild (7.00±
3.69) and severe (7.15 ± 2.93) HFMD patients were signifi-
cantly higher than those in HC (4.52 ± 0.65) (Figure 2(a)).
Moreover, the frequencies of ICOShigh CXCR5+CD4+ TFH
cells (HC: 0.73 ± 0.33; mild: 1.50 ± 1.38; severe: 2.30 ±
2.33) and PD-1highCXCR5+CD4+ TFH cells (HC: 1.07±0.28;
mild: 1.96 ± 1.11; severe: 2.44 ± 1.27) in CD4+ T cells were
similar in both mild and severe cases; they were notably
higher than those of HC (Figures 2(c)-2(d)), respectively.
However, the percentages of circulating CXCR5+CD4+ TFH
cells, ICOShigh, or PD-1highCXCR5+CD4+ TFH cells were
not significantly different between mild and severe HFMD
patients (Figures 2(c)-2(d)). In addition, a strongly positive
correlation was observed between ICOShighCXCR5+CD4+
TFH and PD-1highCXCR5+CD4+ TFH cells (𝑟 = 0.6762;
𝑃 < 0.0001) in EV71-infected patients (Figure 2(b)).
3.2. High Levels of Neutralizing Antibodies against EV71 (NAb-
EV71) with Increased Circulating TFH Cells in Children with
Mild and Severe Infections. The increased frequencies of
circulating TFH cells in human autoimmune thyroid disease
(AITD) including Grave’s disease (GD) and Hashimoto’s
thyroiditis (HT), rheumatoid arthritis (RA), and systemic
lupus erythematosus (SLE) were significantly correlated with
the levels of autoantibodies and disease activity [13, 14, 27–
30]. Next, we sought to examine whether the frequency
of circulating TFH cells was associated with the levels of
specific NAb-EV71 in the mild and severe patients with EV71
infection. It was found that the levels of specific NAb-EV71 in
both mild and severe EV71-patients were significantly higher
than those of HC, but no significant difference was observed
between mild and severe patients (HC: 10.23 ± 7.47; mild:
118.07 ± 108.11; severe: 115.29 ± 101.59) (Figure 3(a)). The
frequencies of circulatingCXCR5+CD4+ TFHcells, ICOShigh,
or PD-1highCXCR5+CD4+ TFH cells were all positively sig-
nificantly associated with the levels of specific NAb-EV71 in
the mild and severe patients, but not with HC, respectively
(Figures 3(b)–3(d)).
3.3. SerumLevels of Cytokines Related to Circulating TFHCells
in Children with Mild and Severe Infections. Recent studies
show that cytokines, both interleukin-21 (IL-21) and IL-6,
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Figure 1: Detection of circulating CXCR5+CD4+ TFH cells with ICOShigh and PD-1high expression in peripheral blood of EV71-infected
patients andHC. Peripheral bloodmononuclear cells (PBMCs) frompatientswith EV71 infection andHCwere stainedwith labeled antibodies
and analyzed by flow cytometry as described in Section 2. The cells were gated initially on living lymphocytes (upper left) and then on CD4+
T cells (upper right). Representative plots of CXCR5+CD4+ TFH cells in the total CD4+ T cells (a); PD-1highCXCR5+CD4+ TFH cells (b); and
COShighCXCR5+CD4+ TFH cells (c).
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Figure 2: Increased percentages of circulating CXCR5+CD4+ TFH cells with ICOShigh and PD-1high expression in peripheral blood of EV71-
infected patients. The percentages of CXCR5+CD4+ TFH cells in the total CD4+ T cells (a); the correlation between the percentages of PD-
1+CXCR5+CD4+ TFH cells and ICOS+CXCR5+CD4+ TFH cells from EV71-infected patients (𝑛 = 60) (b); PD-1+CXCR5+CD4+ TFH cells (c)
and ICOS+CXCR5+CD4+ TFH cells (d). Data shown were the mean ± SD (standard deviation, SD). The horizontal lines show the median.
∗
𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001; ns.: no significant difference.
had critical roles in differentiation and function of follicular
helper CD4+ T cells [14, 21, 30]. The levels of cytokines,
both IL-21 (HC: 66.65 ± 15.88; mild: 92.34 ± 33.26; severe:
101.46±26.82) and IL-6 (HC: 4.94±2.43; mild: 17.68±10.03;
severe: 25.45 ± 21.52) in sera from the patients with EV-71
infection, were notably higher than those of HC, although
no significant difference was found in both mild and severe
children, respectively (Figure 4(a)). The levels of serum IL-
21 were strongly positively correlated with the frequencies of
TFH cells amongHC,mild, and severe patients (Figure 4(b)).
Interestingly, a significant positive correlation between IL-6
levels andCXCR5+CD4+ TFH cells frequencies was observed
between mild and severe patients, respectively, although it
was not found in HC (Figure 4(c)). Interestingly, IL-6 level
showed a significant positive correlation with IL-21 level in
mild and severe-HFMD patients, respectively (Figure 4(d)).
3.4. Correlation between Sera IL-21 and IL-6 and Specific NAb-
EV71 in Children with Mild and Severe Infections. Recent
studies demonstrated that the levels of both IL-21 and
IL-6 cytokines were significantly associated with antibody
expression [14, 21]. In this study, we found that the concen-
trations of serum IL-21 were positively correlated with that of
specific NAb-EV71 in mild or severe patients, although this
correlation was not observed in HC (Figure 5(a)). However,
no significant association was noted between serum IL-6
levels and specific NAb-EV71 concentrations in any of the
three groups tested, respectively (Figure 5(b)).
3.5. Expression of Bcl-6, IL-21, and IL-6 mRNA in Children
with Mild and Severe Infections. Previous studies indicated
that Bcl-6 was a pivotal transcription factor for CD4+ T cell
differentiation into TFH cells [14, 18, 26]. Both IL-21 and IL-
6 share cooperative functions in TFH differentiation and B
cell immunity [21]. Here, we assessed the expression of Bcl-6,
IL-21, and IL-6 mRNA in HC (𝑛 = 15), mild (𝑛 = 10), and
severe (𝑛 = 12) EV71-patients. The IL-6 mRNA expression
in severe patients or mild patients was significantly higher
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Figure 3: Correlation of specific NAb-EV71 titres and circulating CXCR5+CD4+ TFH cells with PD-1high and ICOShigh expression in EV71-
infected patients. (a) Titres of specific NAb-EV71 in sera from HC and EV71-infected patients including mild and severe cases. Relationship
between the titres of specific NAb-EV71 and the frequency of circulating CXCR5+CD4+ TFH cells (b), PD-1+CXCR5+CD4+ TFH cells (c),
and ICOS+CXCR5+CD4+ TFH cells (d). Data shown were the mean ± SD. The horizontal lines show the median. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01;
∗∗∗
𝑃 < 0.001; ns.: no significant difference.
than that in HC, but no significant difference of IL-6 mRNA
expression was observed between mild and severe patients
groups (HC: 10.08 ± 4.16; mild: 18.02 ± 9.41; severe: 20.55 ±
11.38) (Figure 6(a)). Similarly, the IL-21 mRNA expressions
in both mild and severe patients were significantly higher
than those inHC, but no significant difference of IL-21mRNA
was found between mild patients and severe patients (HC:
1.17±0.48; mild: 2.21±1.31; severe: 2.69±1.51) (Figure 6(b)).
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Figure 4: Correlation of cytokines levels and circulating CXCR5+CD4+ TFH cells in EV71-infected patients including mild and severe cases.
(a) Cytokines levels of IL-21 and IL-6 in sera fromHC and EV71-infected patients. (b) Relationship between the IL-21 levels and the frequency
of circulating CXCR5+CD4+ TFH cells. (c) Relationship between the IL-6 levels and the frequency of circulating CXCR5+CD4+ TFH cells.
(d) Relationship between the IL-6 levels and IL-21 levels. Data shown were the mean ± SD.The horizontal lines show the median. ∗𝑃 < 0.05;
∗∗
𝑃 < 0.01; ∗∗∗𝑃 < 0.001; ns.: no significant difference.
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Figure 5: Correlation of specific NAb-EV71 titres and cytokines levels from HC and EV71-infected patients including mild and severe cases.
(a) Relationship between the titres of specific NAb-EV71 and the serum levels of IL-21. (b) Relationship between the titres of specific NAb-
EV71 and the serum levels of IL-6.
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Figure 6: Expression of IL-6, IL-21, and Bcl-6 mRNA in human PBMCs. Human PBMCs from 10 mild and 12 severe patients with EV71
infection, and 15 HC were detected by real-time PCR assay as described in Section 2. (a)The levels of IL-6 mRNA in human PBMCs. (b)The
levels of IL-21 mRNA in human PBMCs. (c) The levels of Bcl-6 mRNA in human PBMCs; data shown were the mean ± SD. The horizontal
lines show the median. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001; ns.: no significant difference.
Moreover, there were no significant differences for Bcl-6
mRNA expression among these groups tested (HC: 23.34 ±
12.92; mild: 18.45±10.28; severe: 19.54±13.32) (Figure 6(c)).
4. Discussion
There aremore than onemillionHFMD cases and 200 deaths
each year since 2008 in China [36]. EV71 is one of the
common causative factors of HFMD in young children less
than 5 years of age [3, 5]. Although mild diseases are the pre-
dominant clinical features of EV71 infection, severe diseases
with neurological involvement and the fetal cases of HFMD
are closely associated with EV71 infection identified by PCR
and/or virus isolation [6–8]. In our study, compared to mild
patients, the age of severe patients wasmainly observed below
3 years (severe versus mild cases, 𝑃 = 0.0016), and evaluated
evidences with WBC numbers (severe versus mild cases, 𝑃 <
0.0001; mild cases versus HC, 𝑃 = 0.0035) and serum CRP
levels (severe versusmild cases,𝑃 < 0.0001; mild cases versus
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HC, 𝑃 < 0.0001) suggested that inappropriate inflammation
may be elicited in the progression of HFMD in the acute
phase of EV71 infection, whichwas consistentwith previously
reported data [7, 31, 32].
Previous studies have demonstrated that both humoral
and cellular immune responses, such as antibodies, B and T
cells including Th1/Th2 and Th17, and other T cell lineages
and related cytokines, play a critical role in protection from
EV71 infection in animal models [4, 34, 35]. In humans, EV71
infection induced imbalance of T/B cells and their related
cytokines and even caused a systemic dysregulation of the
immune system [31–33]. Recent studies show that follicular
helper T cells (TFH), a new T cell subpopulation, play a
pivotal role in regulating immune responses and have been
associated with many diseases [13, 20, 28]. Simpson et al.
reported an increased frequency of circulatingCXCR5+CD4+
TFH cells in patients with systemic lupus erythematosus
(SLE) and Sjogren’s syndrome [30]. Feng et al. demonstrated
that the frequency of circulating TFH cells was significantly
increased in patients with HBV, and these circulating TFH
cells participated in the HBV-related immune responses
[28]. However, the potential role of circulating TFH cells in
patients with EV71 infection is not yet known. In the present
work, we firstly examined the frequency of circulating TFH
cells in mild and severe patients with EV71 infection and
healthy controls.The results demonstrated that the frequency
of circulating CXCR5+CD4+ TFH cells in mild and severe
patients in the acute stage of EV71 infection was significantly
higher than that of HC (severe or mild cases versus HC,
𝑃 < 0.05), respectively. However, severe patients did not
differ significantly from mild patients in the percentage of
peripheral blood CXCR5+CD4+ TFH cells (severe versus
mild cases, 𝑃 = 0.5151). These findings clearly indicated
that TFH cells played an important role in the EV71-induced
immune responses.
Simpson et al. detected that the high frequency of circu-
lating TFH cells with high expression of ICOS and/or PD-
1 molecules was associated with the severity of end-organ
involvement in patients with systemic lupus erythematosus
(SLE) and Sjogren’s syndrome [30]. Zhu et al. demonstrated
the increased frequency of TFH cells with highly expressed
ICOS and/or PD-1 in patients with autoimmune thyroid
disease and rheumatoid arthritis, respectively, and both ICOS
and PD-1 molecules are closely positively correlated with
the function of TFH cells [13]. We detected an enhanced
frequency of PD-1high and ICOShighCXCR5+CD4+ TFH cells
in the mild and severe EV71-induced patients, compared
to HC (severe or mild cases versus HC, 𝑃 < 0.05). In
addition, a closely positive correlation was observed between
the frequencies of these two subpopulations of PD-1high and
ICOShighCXCR5+CD4+ T cells. These data supported the
definition of circulating TFH cells. However, the percentage
of circulating TFH cells with ICOShigh and PD-1high expres-
sion revealed no significant difference between the mild and
severe patients (severe versus mild cases, PD-1high, 𝑃 =
0.1085; severe versus mild cases, ICOShigh, 𝑃 = 0.1930).
In other words, EV71 increased the frequency of circulating
TFH cells with ICOShigh and PD-1high expression that was not
notably associated with the severity of patients in the acute
stage of EV71 infection.
It is known that TFH cells are critical for promoting the
development of antibody response by helper B cells in GC
[10, 11]. Several seroepidemiologic investigations indicated
that the neutralizing antibody can protect adults as well as
children from EV71 infection once again, although the titers
of specific neutralizing antibody were not correlated with
severity of the disease with EV71 infection [3–6, 34, 35].
Why is that? To date, that is not well understood. Our data
also indicated that the serum titers of specific NAb-EV71
in patients with acute stage of EV71 infection were higher
than those in HC (severe or mild cases versus HC, 𝑃 <
0.0001), but no significant difference was observed between
mild and severe patients groups (severe versus mild cases,
𝑃 = 0.9693), which corresponded to previous studies [3].
Additionally, we found that enhanced frequency of circulat-
ing CXCR5+CD4+ TFH, PD-1highCXCR5+CD4+ TFH, and
ICOShighCXCR5+CD4+ TFH cells was notably positively cor-
related with the titres of specific NAb-EV71 in patients with
EV71 infection, and a significant associationwas not observed
between themild and severe patients, respectively.These data
also indicated that TFH cells with ICOShigh and PD-1high
expression participated in regulating antibody responses in
the acute stage of EV71 infection, at the same time, which
might give a good explanation to why there is no significant
difference between the levels of specific NAb-EV71 in both
mild and severe patients with EV71 infection.
Recent studies demonstrated that not only did TFH cells
secrete IL-21, but IL-21 could also drive GC formation and
TFH cell generation and function and promote terminal
mature of B cell in GC, Ig class-switching, and antibody
responses [10, 11, 20]. IL-6 has also induced IL-21 production
and TFH cell generation, and mice lacking both IL-6 and
IL-21 are unable to generate TFH cell-dependent immune
responses [20, 21]. Bcl-6 transcription factor is selectively
expressed in TFH cells, which is required for programming
of TFH cell generation, and Bcl-6 expression is regulated by
IL-6 and IL-21 [14, 21]. In current study, we found that the
levels of sera IL-21 and IL-6 concentrations were significantly
higher in both mild and severe patients with EV71 infection
than those in HC (severe ormild cases versus HC, IL-21/IL-6,
𝑃 < 0.0001), and they were found to be positively correlated
with the frequency of circulating CXCR5+CD4+ TFH cells,
respectively, which suggested that IL-21 and IL-6 might play
an important role in the generation of TFH cells. In addition,
a strongly positive correlation was observed between sera IL-
21 and NAb-EV71 as well as between sera IL-21 and IL-6,
indicating that IL-21 and IL-6 could promote the producing
of specific NAb-EV71, and IL-6 might help in production of
IL-21 cytokines. Furthermore, PCR analysis indicated that
the expression of IL-21 and IL-6 mRNA was significantly
increased in both mild and severe patients compared to HC
(severe or mild cases versus HC, IL-21/IL-6 mRNA, 𝑃 <
0.05). However, no difference of IL-21 and IL-6 cytokines
and mRNA expression was found between mild and severe
patients (severe versus mild cases, IL-21/IL-6 cytokines, 𝑃 =
0.3909/0.3438; IL-21/IL-6 mRNA, 𝑃 = 0.4887/08175); these
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findings indicated that the expression of IL-21 or IL-6 was
not notably related with severity of disease with acute stage of
EV71 infection, and the IL-6 high expression was consistent
with pervious study [7]. Additionally, no significant differ-
ence of peripheral blood Bcl-6mRNA expression amongHC,
mild, and severe patients is consistent with pervious study
which might be associated with formation of memory of
TFH cells [30, 37]. These data revealed that IL-21 and IL-
6 participated in the generation of TFH cells and specific
NAb-EV71 immune responses, which were not significantly
associated with the severity of patients in the acute stage of
EV71 infection.
In conclusion, our data indicated that increased freque-
ncy of circulating TFH cells with ICOShigh and PD-1high
expression was significantly and positively associated with
serum specific NAb-EV71 level and IL-21 and IL-6 con-
centration in patients with EV71 infection, suggesting that
TFH cells and associated cytokines might play a critical
role in regulating humoral responses in the acute stage of
EV71 infection. Further studies on the role of TFH cells in
regulating B cell response and antibody production during
the disease progression of EV71 infection will provide new
insight into understanding the immune pathogenesis of EV71
infection in human.
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